These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 26078483)

  • 1. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
    Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
    Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-206 and miR-132 as Potential Circulating Biomarkers for Mild Cognitive Impairment.
    Xie B; Zhou H; Zhang R; Song M; Yu L; Wang L; Liu Z; Zhang Q; Cui D; Wang X; Xu S
    J Alzheimers Dis; 2015; 45(3):721-31. PubMed ID: 25589731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers.
    Yang TT; Liu CG; Gao SC; Zhang Y; Wang PC
    Biomed Environ Sci; 2018 Feb; 31(2):87-96. PubMed ID: 29606187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
    Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
    Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
    J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
    Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
    J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
    De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
    Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
    Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
    Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
    Kumar S; Vijayan M; Reddy PH
    Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated serum miR-223 servers as biomarker in Alzheimer's disease.
    Jia LH; Liu YN
    Cell Biochem Funct; 2016 Jun; 34(4):233-7. PubMed ID: 27027823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-125b as a biomarker of Alzheimer's disease.
    Tan L; Yu JT; Liu QY; Tan MS; Zhang W; Hu N; Wang YL; Sun L; Jiang T; Tan L
    J Neurol Sci; 2014 Jan; 336(1-2):52-6. PubMed ID: 24139697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
    Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
    Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer's Disease.
    Wen Q; Wittens MMJ; Engelborghs S; van Herwijnen MHM; Tsamou M; Roggen E; Smeets B; Krauskopf J; Briedé JJ
    ACS Chem Neurosci; 2024 Mar; 15(5):1042-1054. PubMed ID: 38407050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Serum miR-146a and miR-155 as Novel Noninvasive Complementary Biomarkers for Ankylosing Spondylitis.
    Qian BP; Ji ML; Qiu Y; Wang B; Yu Y; Shi W; Luo YF
    Spine (Phila Pa 1976); 2016 May; 41(9):735-42. PubMed ID: 27128253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
    He H; Liu A; Zhang W; Yang H; Zhang M; Xu H; Liu Y; Hong B; Yan F; Yue L; Wang J; Xiao S; Xie Z; Wang T
    J Alzheimers Dis; 2021; 83(2):779-790. PubMed ID: 34366343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
    Xie B; Liu Z; Jiang L; Liu W; Song M; Zhang Q; Zhang R; Cui D; Wang X; Xu S
    J Alzheimers Dis; 2017; 55(2):509-520. PubMed ID: 27662297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease.
    Ansari A; Maffioletti E; Milanesi E; Marizzoni M; Frisoni GB; Blin O; Richardson JC; Bordet R; Forloni G; Gennarelli M; Bocchio-Chiavetto L;
    Neurobiol Aging; 2019 Oct; 82():102-109. PubMed ID: 31437718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.
    Dong Z; Gu H; Guo Q; Liang S; Xue J; Yao F; Liu X; Li F; Liu H; Sun L; Zhao K
    Mol Neurobiol; 2021 Jul; 58(7):3084-3094. PubMed ID: 33629272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
    Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
    Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.